Anna Dahlman

The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation

Anne Månsson Kvarnhammar, Niina Veitonmäki, Karin Hägerbrand et al. · Journal for ImmunoTherapy of Cancer · 2019 · 110 citations · Full text

Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells

Rebecka Hellsten, Martin Johansson, Anna Dahlman et al. · PLoS ONE · 2011 · 90 citations · Full text

Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity

Helle J. Jacobsen, Thomas T. Poulsen, Anna Dahlman et al. · Clinical Cancer Research · 2015 · 84 citations

Galiellalactone is a novel therapeutic candidate against hormone‐refractory prostate cancer expressing activated Stat3

Rebecka Hellsten, Martin Johansson, Anna Dahlman et al. · The Prostate · 2007 · 84 citations · Full text

Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance

Mikkel W. Pedersen, Helle J. Jacobsen, Klaus Koefoed et al. · Molecular Cancer Therapeutics · 2015 · 52 citations